The study evaluated the progression risk of advanced neoplasia in patients with mild-moderate dysplasia, a condition linked to esophageal cancer, in rural China from 2010 to 2021.
Out of 1183 patients followed for nearly 7 years, 7.44% developed advanced neoplasia, with a median progression time of 2.39 years.
Key risk factors for progression included older age (55+) and family history of esophageal cancer, suggesting the need for endoscopic monitoring, especially during the first 2 to 3 years post-diagnosis.